Mr. Speaker, we fully agree with the decision to allow the poorest countries, notably those in Africa, to have access to patented drugs for their fight against AIDS. Pharmaceutical research companies have also promised to do their part.
That said, can the Minister of Industry guarantee that this offer to the poor countries will be carried out in accordance with the Patent Act, which protects intellectual property?